New implant could help fight opioid addiction – first safety tests underway
NCT ID NCT07325279
First seen Jan 11, 2026 · Last updated May 04, 2026 · Updated 19 times
Summary
This early-stage study is testing the safety of a nalmefene implant in 24 healthy adults. Nalmefene is a drug that blocks opioid effects, and the implant slowly releases it over weeks. The goal is to see if the implant is safe and how the drug moves through the body, which will guide future studies in people with opioid addiction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID ABUSE AND ADDICTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Premier Research
RECRUITINGMorrisville, North Carolina, 27560, United States
Conditions
Explore the condition pages connected to this study.